Table 5 consultation of other healthcare professionals in neonatal end-of-life decision-making
| Â | All ELDs | Non-treatment decisions | Medication administration | p-value | ||
|---|---|---|---|---|---|---|
Withholding treatment (n= 19% of all cases) | Withdrawing treatment (n= 41% of all cases) | Medication with hastening death taken into account or co-intended (n= 22% of all cases) | Medication with an explicit intention to hasten death (n= 17% of all cases) | |||
Consultation with other physicians/healthcare professionals (multiple answers possible) | ||||||
 Yes, with individual colleagues | 43% | 50% | 44% | 37% | 38% | 0.741 |
 Yes, during an open team meeting | 56% | 39% | 57% | 59% | 67% | 0.212 |
 No | 10% | 12% | 9% | 19% | 0% | 0.189 |
If consulted with other professionals, who? (multiple answers possible) | ||||||
 Neonatologist | 71% | 74% | 68% | 73% | 91% | 0.241 |
 Nurse | 42% | 35% | 40% | 58% | 48% | 0.144 |
 Pediatrician | 30% | 26% | 40% | 23% | 23% | 0.388 |
 Other physician | 27% | 13% | 38% | 27% | 23% | 0.165 |
 Gynecologist | 20% | 52% | 11% | 12% | 22% | <0.001 |
 Family other than the parents | 11% | 9% | 11% | 12% | 13% | 0.980 |
 Othersa | 3% | 0% | 6% | 4% | 0% | 0.444 |
Was an ethics committee consulted? | Â | Â | Â | Â | Â | 0.003 |
 Yes, before the ELD | 2% | 0% | 0% | 0% | 13% |  |
 Yes, after the ELD | 0% | 0% | 0% | 0% | 0% |  |
 No | 98% | 100% | 100% | 100% | 87% |  |